Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
1. In two phase three trials, 16 weeks of lebrikizumab treatment effectively treated adolescents and adults with moderate-to-severe atopic dermatitis. ...
Tag: moderate-to-severe atopic dermatitis
Rocatinlimab may be effective in the treatment of moderate-to-severe atopic dermatitis
1. At week 16, all rocatinlimab groups reported significant improvements in eczema severity. 2. Most treatment-related adverse events were mild-to-moderate, ...
Dupilumab plus topical corticosteroids are effective in the treatment of childhood atopic dermatitis
1. By week 16, 28% of patients in dupilumab reported clear or almost clear skin (IGA 0-1) compared to 4% ...
Abrocitinib is more effective than dupilumab for treatment of moderate-to-severe atopic dermatitis
1. The co-primary endpoints at weeks 2 and 4 were significantly greater with abrocitinib than dupilumab. 2. Overall incidence of ...
Severe atopic dermatitis associated with symptoms of depression and internalizing behaviors in children
1. The findings of this longitudinal cohort study suggest an association between atopic dermatitis and symptoms of depression and internalizing ...
Upadacitinib plus topical corticosteroids is safe and effective for moderate-to-severe atopic dermatitis
1. Upadacitinib combined with topical corticosteroids reduced Eczema Area and Severity Index (EASI) and Investigator’s Global Assessment for atopic dermatitis ...
Upadacitinib monotherapy is effective for patients with moderate-to-severe atopic dermatitis
1. The proportion of patients with EASI ≥75% was significantly greater in the upadacitinib 30 mg and 15 mg groups ...